Immunocore Holdings (IMCR) Debt Ratio (2019 - 2026)
Immunocore Holdings (IMCR) posted quarterly Debt Ratio of 0.37 for Q1 2026, down 3.59% year-on-year from 0.38 in Q1 2025, and little changed on a QoQ basis from 0.37 in Q4 2025.
Immunocore Holdings (IMCR) Debt Ratio (2019 - 2026) Analysis & Trends
Immunocore Holdings (IMCR) has reported Debt Ratio for 8 consecutive years, with 0.37 the latest figure, recorded in Q1 2026.
- Quarterly Debt Ratio fell 3.59% year-over-year to 0.37 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.37 (down 3.59% YoY) and the FY2025 annual result came in at 0.37, down 4.9% from the prior year.
- Debt Ratio was little changed at 0.37 in Q1 2026 per IMCR's latest filing, from 0.37 in the prior quarter.
- Over the last five years, Debt Ratio for IMCR reached as high as 0.44 in Q1 2024 and fell as low as 0.08 in Q4 2023.
- A 5-year average of 0.3 and a median of 0.37 in 2026 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2022 — Debt Ratio fell 26.48% — and 2024, when it soared 394.73%.
- Year by year, Debt Ratio stood at 0.09 in 2022, then declined by 11.33% to 0.08 in 2023, then soared by 381.63% to 0.39 in 2024, then decreased by 4.9% to 0.37 in 2025, then fell by 0.31% to 0.37 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.37, 0.37, and 0.36 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immunocore Holdings | 1.80 Bn | 957.43 Mn | 106.24 Mn | 0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.37 |
| Dec 31, 2025 | 0.37 |
| Sep 30, 2025 | 0.36 |
| Jun 30, 2025 | 0.36 |
| Mar 31, 2025 | 0.38 |
| Dec 31, 2024 | 0.39 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | 0.43 |
| Mar 31, 2024 | 0.44 |
| Dec 31, 2023 | 0.08 |
| Jun 30, 2023 | 0.09 |
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.10 |
| Dec 31, 2021 | 0.12 |
| Dec 31, 2020 | 0.19 |
| Dec 31, 2019 | 0.10 |